Hershberger, Pamela A <br/><br/>
Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells.  [electronic resource] 

 -  The Journal of steroid biochemistry and molecular biology  Aug 2009 
 - 102-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-1220 
<br/><br/><label>Standard No.: </label>10.1016/j.jsbmb.2009.05.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carcinoma, Non-Small-Cell Lung--enzymology<br/>Cell Line, Tumor<br/>Estrogen Receptor beta--agonists<br/>Genistein--pharmacology<br/>Ginsenosides--pharmacology<br/>Humans<br/>Ligands<br/>Lung Neoplasms--enzymology<br/>Mitogen-Activated Protein Kinase 1--genetics<br/>Nitriles--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Sapogenins--pharmacology<br/>Transcription Factors--genetics<br/>Transcription, Genetic<br/>Transfection